Patient characteristics at transplantation for 22 patients younger than 17 years
Patient . | Age, y . | Sex . | Class . | Ferritin (ng/mL) . | GOT (U/L) . | GPT (U/L) . | FS . | No. Tx . | CI . | Outcome . |
---|---|---|---|---|---|---|---|---|---|---|
1 | 8 | F | 3 | 2168 | 33 | 27 | Mi | 44 | 100 | Alive and well |
2 | 7 | M | 3 | 2591 | 49 | 51 | Se | 23 | 100 | Alive and well |
3 | 6 | M | 2 | 6846 | 45 | 54 | Mi | 54 | 100 | Alive and well |
4 | 7 | M | 3 | 532 | 34 | 34 | Se | 58 | 100 | Alive and well |
5 | 4 | M | 2 | 2162 | 23 | 12 | No | 18 | 100 | Alive and well |
6 | 3 | M | 2 | 1390 | 35 | 23 | No | 12 | 49 | Rejection |
7 | 7 | F | 2 | 3048 | 24 | 48 | No | 19 | 100 | Alive and well |
8 | 6 | M | 3 | 3158 | 53 | 32 | Mi | 21 | 100 | Rejection |
9 | 8 | F | 3 | 2448 | 36 | 79 | Mi | 24 | 100 | Alive and well |
10 | 7 | F | 3 | 3231 | 45 | 41 | Mi | 48 | 100 | Rejection |
11 | 5 | M | 2 | 3492 | 31 | 31 | Se | 120 | 38 | Rejection |
12 | 13 | F | 3 | 4578 | 56 | 46 | Mi | 118 | 100 | Dead EBV NHL |
13 | 8 | F | 3 | 2120 | 42 | 64 | Mi | 58 | 100 | Alive and well |
14 | 11 | F | 3 | 2835 | 35 | 45 | Mo | 114 | 100 | Alive and well |
15 | 8 | F | 2 | 1967 | 43 | 32 | Mi | 82 | 100 | Alive and well |
16 | 6 | M | 3 | 1391 | 25 | 29 | Mo | 42 | 100 | Rejection |
17 | 11 | M | 3 | 3386 | 38 | 42 | Mo | 95 | 100 | Dead CMV sepsis |
18 | 12 | M | 3 | 19 801 | 16 | 28 | Mo | 50 | 100 | Alive and well |
19 | 3 | M | 1 | 578 | 35 | 23 | No | 12 | 49 | Rejection |
20 | 8 | F | 2 | 2980 | 36 | 27 | Mi | 51 | 80 | Alive and well |
21 | 6 | F | 1 | 1240 | 28 | 18 | Mi | 68 | 100 | Alive and well |
22 | 14 | M | 3 | 2568 | 31 | 23 | Mi | 125 | 100 | Alive and well |
Patient . | Age, y . | Sex . | Class . | Ferritin (ng/mL) . | GOT (U/L) . | GPT (U/L) . | FS . | No. Tx . | CI . | Outcome . |
---|---|---|---|---|---|---|---|---|---|---|
1 | 8 | F | 3 | 2168 | 33 | 27 | Mi | 44 | 100 | Alive and well |
2 | 7 | M | 3 | 2591 | 49 | 51 | Se | 23 | 100 | Alive and well |
3 | 6 | M | 2 | 6846 | 45 | 54 | Mi | 54 | 100 | Alive and well |
4 | 7 | M | 3 | 532 | 34 | 34 | Se | 58 | 100 | Alive and well |
5 | 4 | M | 2 | 2162 | 23 | 12 | No | 18 | 100 | Alive and well |
6 | 3 | M | 2 | 1390 | 35 | 23 | No | 12 | 49 | Rejection |
7 | 7 | F | 2 | 3048 | 24 | 48 | No | 19 | 100 | Alive and well |
8 | 6 | M | 3 | 3158 | 53 | 32 | Mi | 21 | 100 | Rejection |
9 | 8 | F | 3 | 2448 | 36 | 79 | Mi | 24 | 100 | Alive and well |
10 | 7 | F | 3 | 3231 | 45 | 41 | Mi | 48 | 100 | Rejection |
11 | 5 | M | 2 | 3492 | 31 | 31 | Se | 120 | 38 | Rejection |
12 | 13 | F | 3 | 4578 | 56 | 46 | Mi | 118 | 100 | Dead EBV NHL |
13 | 8 | F | 3 | 2120 | 42 | 64 | Mi | 58 | 100 | Alive and well |
14 | 11 | F | 3 | 2835 | 35 | 45 | Mo | 114 | 100 | Alive and well |
15 | 8 | F | 2 | 1967 | 43 | 32 | Mi | 82 | 100 | Alive and well |
16 | 6 | M | 3 | 1391 | 25 | 29 | Mo | 42 | 100 | Rejection |
17 | 11 | M | 3 | 3386 | 38 | 42 | Mo | 95 | 100 | Dead CMV sepsis |
18 | 12 | M | 3 | 19 801 | 16 | 28 | Mo | 50 | 100 | Alive and well |
19 | 3 | M | 1 | 578 | 35 | 23 | No | 12 | 49 | Rejection |
20 | 8 | F | 2 | 2980 | 36 | 27 | Mi | 51 | 80 | Alive and well |
21 | 6 | F | 1 | 1240 | 28 | 18 | Mi | 68 | 100 | Alive and well |
22 | 14 | M | 3 | 2568 | 31 | 23 | Mi | 125 | 100 | Alive and well |
No. Tx indicates number of red cell transfusions before transplantation; CI, chelation index; GOT, glutamic-oxaloacetic transaminase; GPT, glutamic-pyruvic transaminase; and FS, portal fibrosis (Mi, mild; Mo, moderate; Se, severe; and Ci, cirrhotic).